ASM Communications

ASM Communications

A team of researchers has now engineered a virus nanoparticle vaccine against Bacillus anthracis and Yersinia pestis, tier 1 agents that pose serious threats to national security of the United States.

A new Laboratory Response Network (LRN) protocol covers all aspects of sentinel laboratory biosafety, biosecurity, risk assessment, and biomedical waste management.

Written by Wilbur Chen | Educational board games can initiate important conversations about public health - all while participants have fun!

Microbiology Resource Announcements Editors will permit citing alternative sources, when identified as such and where a permanent public DOI exists.

Four new Governors have been elected to the American Academy of Microbiology’s Board of Governors. Gail Cassell, Lynn Enquist, Mary Estes, and Carey-Ann Burnham will join the Board of Governors for their three-year terms, effective immediately. The ASM and the American Academy of Microbiology (Academy) are excited to welcome this new leadership and look forward to serving the mission of the Academy with them.

A study published this week in mSphere suggests that infants, who are vulnerable to an array of infectious diseases, may have a microbial ally in keeping antibiotic-resistant infections at bay. 

The American Society for Microbiology (ASM) congratulates the House for passing the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPIA) which includes the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provision.

The United States announced today, during the United Nations (UN) General Assembly in New York, The AMR Challenge—the most ambitious global initiative to date to combat the growing threat of antibiotic resistance (AR or AMR). 

Using an artificial intestine they created, researchers showed that the microbiome could quickly adapt to a switch from the medium resembling a western diet to one composed exclusively of dietary fats.. That adaptation involved an increase in the populations of fatty-acid metabolizing species, and a drop in those of protein and carbohydrate metabolizers.

An international team of researchers has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice. In a study published this week in mBio®, an open-access journal of the American Society for Microbiology, the team shows that a live, attenuated version of the Zika virus could form the basis of a new treatment option for this fatal brain cancer. 

Page 1 of 22